The United Kingdom is moving heavily into sequencing through its 100K Genome Project, but the data is of little use without analytical abilities. With this in mind, the U.K. government has coughed up an extra $16 million to find genomics sequence data analysis and interpretation tools.
Poor returns led drug developers to exit the antibiotics sector years ago, only for hospital-acquired infections to become a big, deadly and potentially lucrative problem. Big Pharma is returning to the sector, but two academics have a different idea: crowdsource discovery.
With researchers estimating that as many as 70% of new chemical entities (NCEs) are poorly soluble in water, service providers have scrambled to offer drug delivery technologies that improve bioavailability. But which is right for your active ingredient? Catalent has created software to help answer this question.
Open-source software developers have long stood on the shoulders of giants, incorporating existing tools where possible so they can focus resources on improving other areas. And with the proliferation of open-source genomics programs, Biodatomics is betting on the model working for bioinformatics.
The software is the result of a three-year effort by Rhenovia and its collaborators to develop a computer model for epilepsy that is validated by laboratory experiments. Having created the software, Rhenovia is looking to market it to biopharma companies. The platform could help identify new therapeutic candidates--or reposition existing molecules--and assess their toxicology and safety profiles.
Recognition of the role of protein structure changes in signaling has driven a proliferation of techniques to detect the shifts. Crystallography, dual polarization interferometry and a host of other methods have been tried, but all have flaws. Now, Pfizer and Roche think they have found a better way.
When Google unveiled its antiaging venture Calico, it gave very few details about the nuts and bolts of the company. Now, reports on the questions Calico will look into--and how much cash it will have to answer them--have started to emerge.
Video games have been gaining momentum in healthcare because of various patient benefits, and Genentech's foundation has awarded grant money to propel more games about fighting cancer into the hands of pediatric patients, Medical Marketing & Media reported.
HopeLab has released a new mobile game for children with cancer to play during chemotherapy, seeking to improve adherence to meds and spark positive thoughts during treatment.
With the support of the National Human Genome Research Institute (NHGRI), RTI International plans to enhance a web-based system that enables researchers to connect the dots between complex genetics, health, disease and other data, the group announced.